Online Nutrition Education to Decrease the Side Effects of Chemotherapy in Patients With Breast Cancer
Launched by FRED HUTCHINSON CANCER CENTER · May 23, 2023
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how an online nutrition education program can help women with breast cancer manage the side effects of chemotherapy. Chemotherapy can sometimes cause issues like diarrhea or constipation, which can make it hard for patients to get the nutrients they need. By using a website called Cook for Your Life, this study aims to provide helpful information and support to improve how patients feel during their treatment.
To participate in the trial, women must be at least 18 years old and currently scheduled to receive certain types of chemotherapy for stage I to III breast cancer. They should also be able to read and speak English, have access to a smartphone, tablet, or computer with the Internet, and be willing to complete online surveys and phone assessments throughout their treatment. This trial is not yet recruiting participants, but it represents a promising way to enhance care for women undergoing chemotherapy.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • 18 years of age or older.
- • Stage I-III breast cancer.
- • Current breast cancer patients scheduled to receive ddAC-T(+/-C), TCHP, or TCPembro-AC chemotherapy at Fred Hutch South Lake Union (can enroll prior to receipt of 2nd cycle).
- • Not pregnant and no plan to become pregnant during chemotherapy treatment.
- • Ability to speak and read English.
- • Access to smartphone, tablet, or computer and Internet.
- • Willing and able to complete all study activities through the end of chemotherapy, including completing online questionnaires and telephone assessments.
- • Women must not be pregnant at time of enrollment based on self-report.
- • Able to understand and willing to sign written informed electronic (e) consent in English.
About Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center is a leading nonprofit research institution dedicated to the pursuit of innovative cancer treatments and prevention strategies. Established in Seattle, Washington, the center is renowned for its pioneering work in hematopoietic cell transplantation and its commitment to advancing cancer research through collaborative clinical trials. By integrating cutting-edge science with compassionate patient care, Fred Hutchinson Cancer Center aims to improve outcomes for patients while fostering a multidisciplinary approach to tackling complex cancer challenges. With a strong emphasis on translating research findings into clinical applications, the center is at the forefront of developing novel therapies that offer hope to patients worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Seattle, Washington, United States
Patients applied
Trial Officials
Heather Greenlee
Principal Investigator
Fred Hutch/University of Washington Cancer Consortium
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported